Lilly’s blood cancer drug meets main goal in late-stage study

(Reuters) -Eli Lilly said on Monday its blood cancer treatment Jaypirca met the main goal in a late-stage study in patients who have not received prior treatment.

(Reporting by Mariam Sunny in Bengaluru)